{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-22-000120","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.490219+00:00","generated_at":"2026-06-24T05:57:55.018486+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Surgery Partners Q2 revenue up 13.3% to $615.4M; Adj EBITDA up 13.4% to $86.1M","bullets":["Revenue $615.4M vs $543.3M; net loss $18.4M vs $26.9M in prior year quarter.","Days adjusted same-facility revenues up 6.9%; cases +1.9%, revenue per case +4.9%.","Adj EBITDA ex-CARES grants up 17.8% to $86.0M; margin 14.0%.","2022 guidance reaffirmed: revenue $2.5-2.6B, Adj EBITDA $375-385M.","Deployed ~$90M in six acquisitions at ~7x average multiple; liquidity $227.4M cash plus $203M revolver."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-22-000120","json":"https://secwatch.observer/filing/0001638833-22-000120.json","markdown":"https://secwatch.observer/filing/0001638833-22-000120.md","text":"https://secwatch.observer/filing/0001638833-22-000120.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883322000120/0001638833-22-000120-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883322000120/sgry-20220802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T05:57:55.018486+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}